Litcius/Paper detail

Chronic Inflammation in Obesity and Cancer Cachexia

Rosa Divella, Gennaro Gadaleta‐Caldarola, Antonio Mazzocca

2022Journal of Clinical Medicine26 citationsDOIOpen Access PDF

Abstract

Chronic inflammation has long been linked to obesity and related conditions such as type 2 diabetes and metabolic syndrome. According to current research, the increased risk of cancer in people with certain metabolic diseases may be due to chronic inflammation. Adipocytokines, which are pro-inflammatory cytokines secreted in excess, are elevated in many chronic metabolic diseases. Cytokines and inflammatory mediators, which are not directly linked to DNA, are important in tumorigenesis. Cachexia, a type of metabolic syndrome linked to the disease, is associated with a dysregulation of metabolic pathways. Obesity and cachexia have distinct metabolic characteristics, such as insulin resistance, increased lipolysis, elevated free fatty acids (FFA), and ceramide levels, which are discussed in this section. The goal of this research project is to create a framework for bringing together our knowledge of inflammation-mediated insulin resistance.

Topics & Concepts

MedicineInsulin resistanceMetabolic syndromeInflammationCachexiaAdipokineObesityType 2 diabetesEndocrinologyInternal medicineDiabetes mellitusLipolysisCancerSystemic inflammationImmunologyAdipose tissueAdipokines, Inflammation, and Metabolic DiseasesNutrition and Health in AgingAdipose Tissue and Metabolism
Chronic Inflammation in Obesity and Cancer Cachexia | Litcius